Science News & Science Current Events
 

Tuberculosis Current Events | Tuberculosis News | 7
Page 7 of 8 | 197 Results
Previous0102030405060708   Next   
Sort By: Page Views | Date
Pharmaceutical Interests Versus AIDS In Africa (p 89)
The appointment of Randall Tobias as the US Government's global AIDS co-ordinator is analysed in this week's editorial. Tobias will head up a $15 billion programme to tackle AIDS in the African and Caribbean countries most devastated by the pandemic, although sceptics point out that his lack of... view more (2003-07-09)

South Africa In Denial Over Number Of Deaths From HIV/AIDS
A recent study attempting to quantify misclassification of HIV/AIDS deaths concluded that for the year 2000-01, the number of deaths related to HIV/AIDS was likely to be almost three times as high as that published in the Government's statistical report compiled from death certificates. The study... view more (2005-02-09)

Promising diagnostic test for sleeping sickness (pp 1337, 1358)
Around half a million people a year in sub-Saharan Africa are affected by sleeping sickness (human African trypanosomiasis). The disease is fatal in humans if not treated with chemotherapy; however, adverse effects of drug treatment and an increase in drug resistance underline the importance of... view more (2004-04-21)

Chemistry & Industry - 20 May Issue
Chemistry & Industry Issue 10 - Cover Date Monday 20 May 2002 NEWS Bionic tongue constructed from neck muscle (page 7) A bionic tongue that is part-organic, part-electronic has been developed by scientists to replace organs lost through cancer or accidents. NEWS FEATURE From field to stomach... view more (2002-05-17)

Whose Interests Does The World Trade Organisation Serve? (P 269)
This week's Lancet editorial calls for the World Trade Organisation (WTO) to clarify the alteration of trading restrictions to enable poor countries to access affordable medicines. The USA recently rejected a proposal for a global deal which would enable less-developed countries to override patent... view more (2003-01-23)

An alternative therapy against brucellosis
Concepci√≥n Lec√°roz, a researcher from the University of Navarra, has developed a new therapy against brucellosis.   view more (2006-01-18)

Gide's forgotten love story published after 95 years
An expert at the University of Sheffield has been instrumental in unearthing a previously undiscovered manuscript from a renowned and controversial French writer.   view more (2002-11-13)

Violence Against Women (pp 1172, 1232)
This week marks the start of a new Lancet series-Violence against Women. Over the next six weeks, the series will discuss current challenges and debates on violence against women and the implications for public health. In the first article, Charlotte Watts and Cathy Zimmerman from the London School... view more (2002-04-04)

EDCTP welcomes G8 support for HIV/AIDS vaccine development
On 10th June 2004 during this year's summit in Sea Island, Georgia, the G8 Leaders called for the establishment of a Global HIV Vaccine Enterprise: a virtual consortium to accelerate HIV vaccine development by enhancing coordination, information sharing, and global collaboration. The EDCTP is... view more (2004-06-11)

Five more African countries to benefit from Schistosomiasis Control Initiative
Another five countries from across Africa have today been informed that they will benefit from a multi-national project to tackle schistosomiasis. Burkina Faso, Mali, Niger, Zambia and Tanzania, will be supported by the Schistosomiasis Control Initiative (SCI), based at Imperial College London and... view more (2003-11-24)

Research Fortnight 29 May issue: stories on space science, the spending review, Diamond, energy and veterinary research.
UK space science dead in 10 years, group warns The UK's influence in space science will vanish within the next decade if current trends in funding are not reversed, according to a new campaign group. The Space Action Network aims to raise awareness of the problems faced by the space science... view more (2002-05-29)

Fresh Hopes For Treatment Of Malaria In Africa (p 1218)
Despite the large number of deaths caused worldwide by AIDS, tuberculosis, and diarrhoeal diseases such as cholera, the biggest infectious-disease killer is still malaria, especially in Africa. Efforts to eradicate the carrier of malaria, a mosquito, have been only partly successful. The standard... view more (2001-10-10)

University of Arizona scientist shares in discovery of microbe filaments' power
Researchers from The University of Arizona and Columbia University have discovered that tiny filaments on bacteria can bundle together and pull with forces far stronger than experts had previously thought possible.   view more (2008-04-21)

European Commission funded research leads to effective new malaria drug
In an article published in the latest issue of The Lancet 1) , an international consortium, funded by a EUR1.8 million research grant from the European Commission, reports successful efficacy trials of a new candidate drug against malaria. If these initial results are confirmed a new drug could be... view more (2002-12-13)

Concern for European public health as EU border extends to the east (p 1339, 1389)
Public-health experts writing in this week's issue of THE LANCET caution that the widening of the European Union (EU) to the east could have potentially adverse effects on public health - both for the new member countries, many of whom have poor health-care infrastructure, and for existing EU... view more (2004-04-21)

UC research discovers new way to fight antibiotic-resistant bacteria
Research by a team at the University of Cincinnati (UC) has helped in the discovery of a new way to fight antibiotic-resistant bacteria, responsible for preventing treatment of lung infections in patients with cystic fibrosis and life-threatening cases of pneumonia.   view more (2007-03-19)

Older antibiotic gains new respect as potent treatment for tuberculosis
It has no current market, not even a prescription price. Its makers stopped commercial production years ago, because demand was so low.   view more (2007-12-18)

Infliximab scheduled treatment has proven to be an effective strategy in IBD patients
Crohn's disease (CD) and ulcerative colitis (UC) are chronic-relapsing diseases, the clinical courses of which are characterized by periods of remission and periods of acute flare up, determining clinical symptoms which have a strong impact on the quality of life for patients.   view more (2007-10-25)

Little lifesavers — Nanoparticles improve delivery of medicines and diagnostics
Tiny, biodegradable particles filled with medicine may also contain answers to some of the biggest human health problems, including cancer and tuberculosis. The secret is the size of the package.   view more (2007-04-11)

New way to make malaria medicine also first step in finding new antibiotics
University of Illinois microbiology professor William Metcalf and his collaborators have developed a way to mass-produce an antimalarial compound, potentially making the treatment of malaria less expensive.   view more (2008-09-29)

D-cycloserine may improve behavioral therapy treatment for anxiety
Anxiety is a normal human response to stress, but in some, it can develop into a disabling disorder of excessive and irrational fears, such as obsessive-compulsive disorder, panic disorder, or posttraumatic stress disorder. Effective treatments are available and can involve either behavioral... view more (2008-07-17)

Bovine tuberculosis in wildlife threatens endangered lynx and cattle health
In an epidemiological survey of Spain's Doñana National Park, the findings of which are published on July 23 in the journal PLoS ONE, Christian Gortázar and colleagues studied the prevalence of bovine tuberculosis (bovine TB) infection among populations of wild boar, red deer and... view more (2008-07-23)

Scientists sequence Nature's antibiotic factory
The genome sequence of Streptomyces coelicolor, one of the family of common soil bacteria that produce more than two thirds of the world's antibiotic medicines, will be published in the journal Nature this week. Streptomyces are almost ubiquitous in the soils and are responsible for its familiar... view more (2002-05-06)

New Guidelines for Treating Rheumatoid Arthritis
Proven combinations of medicines and the introduction of new anti-arthritis drugs have significantly improved the treatment of rheumatoid arthritis (RA), according to guidelines issued by the American College of Rheumatology and co-authored by physicians at the University of Alabama at Birmingham... view more (2008-07-23)

University to develop new TB vaccine
A research team at Aston University has been awarded EU funding of almost half a million euros to investigate one of the most pressing problems in medicine today -the need to develop new vaccinations against Tuberculosis (TB). TB is one of the biggest killers in the world, particularly in... view more (2004-02-11)
Page 7 of 8 | 197 Results
Previous0102030405060708   Next   
Sort By: Page Views | Date
© 2008 BrightSurf.com